Literature DB >> 24432252

Evolving approaches and resources for clinical practice in the management of HIV infection in the HAART era.

Giovanni Guaraldi.   

Abstract

Physicians treating HIV infection concentrate not only on the viral management but they also have to take into account the potential age and lifestyle-related conditions likely to influence long-term morbidity, correlated with patients' survival. Hypertension, diabetes, cardiovascular, bone, kidney and liver disease, better than opportunistic infection, depict the changing spectrum of HIV disease in the HAART era. These conditions, the so called non infectious co-morbidities, are age-related diseases affecting the general population. However, their prevalence in HIV-infected individuals is higher, with earlier onset, probably as a result of the complex inter-relationship between HIV infection, co-infection and antiretroviral therapy. Regular screening for non infectious co-morbidities helps identify those asymptomatic HIV-infected individuals who are most at risk of developing comorbidities; this means that appropriate intervention, either by lifestyle changes to reduce modifiable risk factors or by the use of pharmacological management, can be initiated.

Entities:  

Keywords:  HAART; HIV; metabolic clinic; non infectious co-morbidities

Year:  2011        PMID: 24432252      PMCID: PMC3882823          DOI: 10.11599/germs.2012.1002

Source DB:  PubMed          Journal:  Germs        ISSN: 2248-2997


  5 in total

1.  Improvements in subcutaneous fat, lipid profile, and parameters of mitochondrial toxicity in patients with peripheral lipoatrophy when stavudine is switched to tenofovir (LIPOTEST study).

Authors:  Esteban Ribera; José Carlos Paradiñeiro; Adria Curran; Silvia Sauleda; Elena García-Arumí; Eva Castella; Carolina Puiggròs; Manuel Crespo; Maria Feijoo; Marjorie Diaz; Sara Villar Del Saz; Merçè Planas; Delia Sureda; Vicenç Falcó; Imma Ocaña; Albert Pahissa
Journal:  HIV Clin Trials       Date:  2008 Nov-Dec

Review 2.  Accelerated immune senescence and HIV-1 infection.

Authors:  Victor Appay; Jorge R Almeida; Delphine Sauce; Brigitte Autran; Laura Papagno
Journal:  Exp Gerontol       Date:  2007-01-08       Impact factor: 4.032

Review 3.  Evolving perspectives on HIV-associated lipodystrophy syndrome: moving from lipodystrophy to non-infectious HIV co-morbidities.

Authors:  Giovanni Guaraldi; Ioannis G Baraboutis
Journal:  J Antimicrob Chemother       Date:  2009-07-03       Impact factor: 5.790

4.  A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.

Authors:  A Carr; K Samaras; S Burton; M Law; J Freund; D J Chisholm; D A Cooper
Journal:  AIDS       Date:  1998-05-07       Impact factor: 4.177

5.  Improved survival in HIV-infected persons: consequences and perspectives.

Authors:  Nicolai Lohse; Ann-Brit Eg Hansen; Jan Gerstoft; Niels Obel
Journal:  J Antimicrob Chemother       Date:  2007-07-02       Impact factor: 5.790

  5 in total
  6 in total

Review 1.  General and advanced diagnostic tools to detect Mycobacterium tuberculosis and their drug susceptibility: a review.

Authors:  Md A Gazi; Md R Islam; Mohammad G Kibria; Z Mahmud
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-01-06       Impact factor: 3.267

Review 2.  Recent advances in the diagnosis of Mycobacterium tuberculosis.

Authors:  Philip Ifesinachi Anochie; Edwina C Onyeneke; Angelina C Ogu; Anthony C Onyeozirila; Srikanth Aluru; Nneka Onyejepu; Jian Zhang; Lauretta Efere; Mariam A Adetunji; Juan Gabriel Bueno Sánchez
Journal:  Germs       Date:  2012-09-01

Review 3.  Milk-borne infections. An analysis of their potential effect on the milk industry.

Authors:  Revathi Dhanashekar; Sindhura Akkinepalli; Arvind Nellutla
Journal:  Germs       Date:  2012-09-01

4.  Cardiac involvement in HIV-positive patients.

Authors:  Efrat Daglan; Dan Yamin; Bogdana Manu; Anca Streinu-Cercel
Journal:  Germs       Date:  2013-03-01

5.  Serum adipokines and HIV viral replication in patients undergoing antiretroviral therapy.

Authors:  Victoria Aramă; Cătălin Tilişcan; Daniela Adriana Ion; Raluca Mihăilescu; Daniela Munteanu; Anca Streinu-Cercel; Ana Maria Tudor; Adriana Hristea; Viorica Leoveanu; Ioana Olaru; Stefan Sorin Aramă
Journal:  Germs       Date:  2012-03-01

6.  Impact of HIV-1 tropism on the emergence of non-AIDS events in HIV-infected patients receiving fully suppressive antiretroviral therapy.

Authors:  Gaetano Maffongelli; Claudia Alteri; Elisa Gentilotti; Ada Bertoli; Alessandra Ricciardi; Vincenzo Malagnino; Valentina Svicher; Maria M Santoro; Luca Dori; Carlo F Perno; Massimo Andreoni; Loredana Sarmati
Journal:  AIDS       Date:  2016-03-13       Impact factor: 4.177

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.